Thus, several studies have addressed the role of EVI1 in protecting cells from apoptotic stimuli, yet little information is available regarding a possible effect of EVI1 on cellular resistance to drugs used in the therapy of AML. This evidence concerns the gene MECOM and acute myeloid leukemia.